More than 200 million people worldwide live with food allergy, especially to peanuts — one of the most dangerous forms. But over the past few years, there have been real breakthroughs that are gradually changing life for people with allergies.
Instead of painful injections, drops, powders and patches are now available — especially effective for young children. In 2023, the drug Xolair (omalizumab), which blocks the IgE molecule, was approved: in 67% of children with severe allergy, it increased tolerance to peanuts. The LEAP study showed that if peanuts are introduced into infants' diets, the risk of allergy falls by 86%, and this effect lasts for years.
Scientists are also testing Regeneron drugs that may be able to "erase" the immune system's memory of allergens, and mRNA technologies are opening up a new path to therapy.
Scientists hope this could lead not just to reduced sensitivity, but to complete freedom from allergy. Even now, life for people with allergies is becoming safer, and the future — much freer.
